The aim of this study was to determine both the occurrence and the genetic basis of resistance to erythromycin among 1 235 Staphylococcus spp. isolates obtained between 2000 and 2006 from (a) raw milk and meat (1 704 samples), (b) foodstuffs produced from these (451 samples), and (c) contact surfaces at processing plants and dairy farms (363 samples) in the Czech Republic. Isolates were screened by broth microdilution method for resistance to erythromycin and further 11 antimicrobial agents. In addition, isolates were screened by agar dilution (erythromycin range 1-128 mg/l) and D-zone test for inducible resistance to macrolides, lincosamides and streptogramin B (iMLS B ). Forty isolates were found to be either resistant, or intermediate, to erythromycin (3.2% of isolates); of these, more than 50% were identified as S. epidermidis. A total of 15 (1.2%) resistant isolates of staphylococci originated from foodstuffs. Resistance mediated by methylation -i.e. iMLS B -resistance (10 isolates with the erm(A) or erm(C) gene) and constitutive MLS B -resistance (one isolate with the erm(B) and erm(C) genes) -exhibited a significantly high level of resistance to erythromycin with minimum inhibitory concentrations (MIC) of 64 ->128 mg/l (MIC mode = >128 mg/l). In contrast, the efflux mechanism encoded by the msr(A) gene (13 isolates; MIC range = 4-128, MIC mode = 128 mg/l), the inactivation mechanisms of resistance encoded by the mph(C) gene (three isolates; MIC range = 8-32 mg/l), and/or their combination (13 isolates; MIC range = 4-128, MIC mode = 64 mg/l) led to lower MIC values. The efflux gene msr(A) dominated among the erythromycin-resistant isolates (65% of resistant isolates). This first report on the resistance of Staphylococcus spp. to erythromycin in the Czech Republic illustrates that, while occurrence was low, isolates from food were nevertheless carriers of erm(A), erm(B), erm(C), msr(A) and mph(C) genes for resistance to erythromycin and, therefore, represent a potential thread to humans.
Macrolides are antibiotics widely used for the treatment of human and animal infections. The use of these antibiotics has been accompanied by selection of resistant bacteria, e.g. staphylococci (Schlegelova et al., 2002) . Resistant bacteria, or genetic determinants of resistance, can be transmitted from animals to humans via foodstuffs (Perreten et al., 1998; Schlegelova et al., 2004) . In addition to pathogenic Staphylococcus aureus, potentially pathogenic coagulase-negative staphylococci (CoNS) have also been identified as carriers of genes for resistance to macrolides (Jensen et al., 1999; Luthje and Schwarz, 2006) .
To date, 65 genes have been found to mediate different mechanisms of resistance to macrolides (including target site modification by methylation of rRNA as well as efflux or enzymatic inactivation of macrolides) in both Gram-positive and Gramnegative microorganisms (http://faculty.washington.edu/marilynr/ermwebA.pdf, 2007). Among these genes, erm(A), erm(C) and msr(A) have been detected in Staphylococcus, alone or in combination, more frequently than other genes (Eady et al., 1993; Lina et al., 1999; Luthje and Schwarz, 2006; Bagcigil et al., 2007) . The methylation of rRNA leads to cross-resistance to macrolides, lincosamides and streptogramin B (MLS B -resistance), which can be either constitutive (cMLS B ) or inducible (iMLS B ) (Weisblum, 1985) . High-level resistance to MLS B antibiotics can be induced by subinhibitory concentrations (0.01-0.1 μg/ml) of erythromycin (Matsuoka et al., 2002) .
It is clinically important to differentiate between isolates with iMLS B resistance encoded by erm genes and isolates with efflux-mediated resistance due to the msr(A) gene (Leclercq, 2002) . Fiebelkorn et al. (2003) described a practical disc diffusion method for the differentiation of erythromycinresistant isolates and detection of iMLS B -resistant strains (D-zone test). The therapeutic effect of lincosamides is maintained in erythromycin-resistant strains with the msr(A) gene, but the same agents favor the switch from the inducible to the constitutive type of erm expression and can be a cause of unsuccessful therapy with lincosamides (Drinkovic et al., 2001 ).
To date, no study assessing the potential danger of transmitting this type of resistance through foods of animal origin has been carried out in the Czech Republic. Therefore, the primary aim of this study was to critically evaluate the occurrence of erythromycin resistance in staphylococcal isolates from samples related to the human food chain in the Czech Republic. The second aim was to assess the genetic basis of the resistance to erythromycin among the isolates.
MATERIAL AND METHODS

Samples
A total of 2 518 samples (Table 1) 
Staphylococcal isolates
Samples were cultivated in parallel on Baird-Parker agar (Merck, Darmstadt, Germany) and KRANEP agar (Merck). A maximum of five suspected morphologically dissimilar colonies of Staphylococcus were cultivated onto blood agar plates containing 5% sheep blood and identified using the catalase test, oxidase test, bacitracin and furazolidon susceptibility disk diffusion tests, the coagulase test and, biochemically, by the STAPHytest 24 identification system (Pliva-Lachema, Brno, Czech Republic). Not more than one isolate of the same species from a single sample were included in this study. The isolates were stored in tryptose soy broth (TSB; Oxoid, Basingstoke, UK) supplemented with 20% glycerol at 80°C until studied.
Antimicrobial testing
Determination of minimum inhibitory concentrations (MICs). A total of 1 235 isolates of Staphylococcus were examined for resistance to antimicrobial agents. MICs for ampicillin/sulbactam, benzylpenicillin, chloramphenicol, ciprofloxacin, clindamycin, erythromycin, gentamicin, oxacillin, sulphamethoxazole/trimethoprim, teicoplanin, tetracycline and vancomycin were determined using a standardized microdilution test (Veterinary plate for staphylococci, Trios, Prague, Czech Republic) and, furthermore, for erythromycin (Sigma-Aldrich, Prague, Czech Republic; range 1-128 mg/l) using the agar dilution method in accordance with the Clinical and Laboratory Standards Institute (2006a). The MIC interpretative criteria were based on the recommendations given in document M100-S16 of the Clinical and Laboratory Standards Institute (2006b). S. aureus ATCC 25923 served as a reference strain for quality control purposes.
Determination of the inducible type of MLS B resistance. A total of 40 isolates resistant and intermediate to erythromycin identified on the basis of their MICs were examined using the disc diffusion test (D-zone test) with erythromycin (15 µg) and clindamycin (2 µg) discs (Oxoid) according to the method of Fiebelkorn et al. (2003) . A flattening of the zone of growth inhibition around the clindamycin disk in the part adjacent to the erythromycin disk indicated inducible macrolide, lincosamide and streptogramin B (iMLS B ) resistance.
Detection of genes encoding erythromycin resistance
Template DNA was obtained by lysis of cells from a bacterial culture induced by boiling. PCR detection of erm(A), erm(B), erm(C), msr(A) and mph(C) genes was performed as previously described (Sauer et al., 2008 ) with a few modifications. PCR cycles consisted of an initial denaturation step (94°C for 5 min) followed by 30 amplification cycles (dena- Table 2 .
RESuLTS AND DISCuSSION
Prevalence of erythromycin-resistant staphylococcal isolates
Out of a total of 1 235 isolates of Staphylococcus spp. of various origins ( In selecting interpretative criteria for evaluating resistance, it was necessary to consider isolates as carriers of resistance genes that can cause problems, and particularly in the therapy of humans. Therefore, we selected the criteria for clinical laboratories cited by the Clinical and Laboratory Standards Institute (CLSI) (2006b) to interpret resistance. In this study, 40 isolates were found to be resistant or intermediate to erythromycin (3.2% of isolates, Table 3 ). Of these, more than 50% were identified as S. epidermidis (21 isolates, Table 4 ). Other species found were S. aureus (8 isolates), S. haemolyticus (5 isolates), S. xylosus (two isolates), S. warneri (one isolate), and three isolates that could not be identified to species level by the tests applied and are therefore referred to as coagulase-negative staphylococci (CoNS).
Raw milk displayed a rather low level of contamination with erythromycin-resistant isolates relative to the total number of isolates from milk (2.04%; Table 3 ). Therefore, a lower frequency of erythromycin-resistant staphylococci was also expected in final products, which were manufactured only from pasteurized milk (73-76°C, 15-20 s). However, the relative number of resistant isolates increased to 3.04%. Also surprising was the higher number of erythromycin-resistant isolates from the surfaces of milk plant equipment (5.13%), all of which were S. epidermidis. S. epidermidis has been shown to have the ability to adhere to stainless steel surfaces (Moretro et al., 2003) , and a correlation between resistance to antimicrobial agents and the ability to create biofilms has been shown particularly in human medicine (Klingenberg et al., 2005) . On the basis of these findings, we can assume that the final milk products in the present study were contaminated secondarily, through strains released from the surfaces of the processing equipment. Significantly more erythromycin-resistant isolates were extracted from raw meat (Fisher's test; P < 0.05) than from raw milk (5.41% versus 2.04%). Further, final meat products were contaminated more often in comparison with milk products (8.33% versus to 3.04%), but that difference was not statistically significant (Fisher's test; P > 0.05). In the meat processing plants, no processing steps were included that would eliminate with certainty all microorganisms during the processing of raw meat. It is more likely, therefore, that contamination by microorganisms was caused by transfer from animals, as opposed to transfer from the surfaces of processing equipment, since erythromycin-resistant staphylococci were not isolated from the processing equipment and, in general, the number of isolates in this group was low (22 isolates; Table 3 ).
Comparable studies that examined resistance to erythromycin of Staphylococcus isolates, albeit directly from clinical cases of animal illnesses, indicate an occurrence of 7.4% erythromycin-resistant CoNS isolates from cows suffering from subclinical mastitis (Luthje and Schwarz, 2006) , and in 26.3% (31 of 118) of samples of clinically isolated staphylococci from poultry (Aarestrup et al., 2000) . Resistance to erythromycin occurred in 38% of isolates of S. aureus from pigs, but not among another 300 animals (equal numbers of dogs, horses and cows) that were a part of the same study (Bagcigil et al., 2007) . Based upon both these results and our results, we believe the prevalence and penetration of erythromycin-resistant staphylococci in the food chain is not high, although not negligible. A higher risk for transfer of resistant isolates was shown for final meat products in the Czech Republic than for milk (Table 3) .
Analysis of the genetic basis of erythromycin-resistant isolates
At least one of the genetic determinants of resistance was detected in all erythromycin-resistant isolates in this study (MIC R range 8 to >128 mg/l). The inducible phenotype of resistance to MLS B antibiotics was detected in 10 isolates (Table 4) with susceptibility to clindamycin (MIC CLI = 0.03-0.25 mg/l). The inducibly expressed genes erm(A) and erm(C) were present alone (both in five isolates), while in one isolate of S. haemolyticus the erm(C) gene was detected in combination with the erm(B) gene. This isolate was resistant to macrolides and lincosamides as identified on the basis of MIC values for erythromycin and clindamycin of >128 mg/l and 8 mg/l, respectively. The constitutive phenotype of resistance corresponded in this isolate with the constitutive expression of the erm(B) gene, which is indicative for staphylococci (Lina et al., 1999) . The simultaneous presence of more than one erm gene in the genome is possible and has previously been detected in staphylococci (Eady et al., 1993; Jensen et al., 1999; Luthje and Schwarz, 2006) .
In addition to high resistance to erythromycin, which significantly differentiated erm positive isolates (MIC 90 = >128 mg/l), resistances to at least one other antimicrobial agent were also noted (Table 4) . Multiple resistance to erythromycin, penicillin, and tetracycline, or in combination with other resistance phenotypes, was noted in seven isolates (64.0%). High concurrent resistance to other antimicrobial agents has also been reported by other authors, such as Leclercq (2002) , and it may indeed be characteristic for this type of resistance. In this study, however, we could not confirm the correlation reported for erm(A) genes, constitutive expression and resistance of staphylococci strains to methicillin, or that for erm(C) genes, inducible expression and sensitivity to methicillin (Lina et al., 1999) .
Twenty-six isolates resistant to erythromycin carried the msr(A) gene, which codes for an ATPdependent efflux pump (Table 4 ). This gene occurred in the studied staphylococci more often = 128 mg/l). As previously described, the genes msr(A) and mph(C) were usually physically linked in staphylococci (Luthje and Schwarz, 2006) . Our results indicate that the msr(A) gene occurs more often in environments associated with animals than has been previously indicated in, for example, isolates from humans (Eady et al., 1993) . The higher occurrence is evidenced by findings of genes in isolates extracted from the genera Streptococcus, Enterococcus, Corynebacterium and Pseudomonas, all of which are highly homologous with the msr(A) gene in the case of Staphylococcus (99 to 100%) (Ojo et al., 2006) . The mph(C) gene was detected in 13 isolates in combination with msr(A) genes, as well as independently of msr(A) in two isolates of S. xylosus (MIC = 4 and 32 mg/l) and in one isolate of S. epidermidis (MIC = 16 mg/l). Resistance to other antimicrobial agents was not noted in these cases. This gene has been detected in S. aureus, and only in connection with the msr(A) and erm genes (Matsuoka et al., 1998 (Matsuoka et al., , 2002 . Our data are in agreement with the results of the study by Luthje and Schwarz (2006) , who detected the gene independently in two isolates, S. equorum and S. xylosus, and with MIC values for erythromycin of 8 and 16 mg/l, respectively.
The msr(A) and mph(C) genes, independently or in combination, were detected also in three isolates (S. aureus 2×, S. xylosus 1×; Table 4 ) with MIC to erythromycin of 4 mg/l, which is upper boundary of the intermediate category. Repeated determination of MIC values for these isolates excluded the possibility of an error in performing the test.
CONCLuSION
Based upon the results of this study, we can state that, in the Czech Republic, the occurrence of Staphylococcus isolates resistant to erythromycin was low in milk from cattle and in foods of animal origin. Although the findings are not alarming, this first report on the resistance of Staphylococcus spp. to erythromycin in the Czech Republic indicates that isolates from foodstuffs were carriers of erm(C), msr(A) and/or mph(C) genes for resistance to erythromycin and, therefore, represent a potential thread to humans. A higher prevalence of such the isolates was found in meat products when compared with milk products. The results from this study indicate that the msr(A) gene occurs more often in staphylococci from animal environments than previously presented in clinical isolates from humans.
